Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39787 |
KRH-3955 hydrochloride
|
||
KRH-3955 hydrochloride is a CXCR4 antagonist with oral bioavailability. It effectively inhibits the binding of SDF-1α to CXCR4, exhibiting an IC 50 of 0.61 nM. Additionally, KRH-3955 hydrochloride displays high potency and selectivity as an inhibitor of X4 HIV-1, with an EC 50 ranging from 0.3 to 1.0 nM. | |||
T27742 |
KRH-3955 Salt
KRH-3955,KRH3955,KRH 3955,KRH3955 Salt |
||
KRH-3955, a CXCR4 antagonist, is an orally bioavailable and extremely potent inhibitor of HIV-1 infection. |